Product NDC: | 63323-125 |
Proprietary Name: | GEMCITABINE HYDROCHLORIDE |
Non Proprietary Name: | GEMCITABINE |
Active Ingredient(s): | 1 g/25mL & nbsp; GEMCITABINE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-125 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090799 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110726 |
Package NDC: | 63323-125-50 |
Package Description: | 25 mL in 1 VIAL (63323-125-50) |
NDC Code | 63323-125-50 |
Proprietary Name | GEMCITABINE HYDROCHLORIDE |
Package Description | 25 mL in 1 VIAL (63323-125-50) |
Product NDC | 63323-125 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | GEMCITABINE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110726 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | GEMCITABINE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | g/25mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |